Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
4 hedge funds and large institutions have $15K invested in Onconova Therapeutics, Inc. Warrants in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
43% less funds holding
Funds holding: 7 → 4 (-3)
98% less capital invested
Capital invested by funds: $611K → $15K (-$596K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$280 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$172K |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$72K |
| 3 |
LYV
Live Your Vision
West Conshohocken,
Pennsylvania
|
-$1K |
ONTXW Hedge Fund Activity: Q2 2018 in Review
4 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q2 2018, worth a combined $15K — down 98% from $611K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ONTXW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $280. The largest seller was 683 Capital Management, exiting entirely with an estimated $172K sold.
- 4 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q2 2018, down from 7 in Q1 2018.
- Funds reported $15K of Onconova Therapeutics, Inc. Warrants stock for Q2 2018, down 98% quarter-over-quarter.
- 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q2 2018 and 3 closed out, a net change of -3 holders.
- The largest Onconova Therapeutics, Inc. Warrants buyer in Q2 2018 was UBS Group, an estimated $280 added.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q2 2018 was 683 Capital Management, an estimated $172K sold.
Based on aggregated 13F filings for Q2 2018.